Bronte Amalthea Fund Incurred Loss in Karuna Therapeutics (KRTX) Short Position
Bronte Capital, an investment management company, released its “Amalthea Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
March 4th, 2024 - Hedge Fund Investor Letters News
March 4th, 2024 - Hedge Fund Investor Letters News
March 4th, 2024 - Hedge Fund Investor Letters News
November 7th, 2023 - Hedge Fund Investor Letters News
November 7th, 2023 - Hedge Fund Investor Letters News
November 7th, 2023 - Hedge Fund Investor Letters News
June 29th, 2023 - Hedge Fund Investor Letters News
June 29th, 2023 - Hedge Fund Investor Letters News
June 29th, 2023 - Hedge Fund Investor Letters News
June 29th, 2023 - Hedge Fund Investor Letters News
Returns since its inception in May 2014 (through November 14th, 2024)